Credelio Quattro is a drug owned by ELANCO US INC. It is protected by 2 US drug patents filed from 2030 to 2041. All patents are active. Details of Credelio Quattro’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US8383659 | 17 Jan, 2030 | Active |
Exclusivity Information
Credelio Quattro holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2027. Details of Credelio Quattro's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Oct 07, 2027 |
About Credelio Quattro
Credelio Quattro is a drug
owned by ELANCO US INC.
Credelio Quattro uses
Lotilaner, Moxidectin, Praziquantel, Pyrantel Pamoate as the active
ingredients.
Active Ingredient:
Credelio Quattro uses
Lotilaner,
Moxidectin, Praziquantel, Pyrantel Pamoate
as the active ingredients.
Check out other Drugs and Companies using
Lotilaner, Moxidectin, Praziquantel, Pyrantel Pamoate ingredient.